Letter to the Editor advocating limiting of antidepressants instead of gun rights.
MP warns that Canadians blind to dangers of prescription drugs
“Dear Mr. Vice President: In the wake of the unimaginable tragedy at Sandy Hook Elementary School, there has been an understandable assumption that increased use of mental health services and a mental registry is part of the solution. Understandable, but wrong.”
Antidepressants Give Soderbergh a Thriller’s Plot
Medical Pharmaceutical Complex Exposed – “…438 people died in drug trials run by Bayer Healthcare, Bristol Mayer Squibb, Sun Pharmaceutical and Dr Reddy’s Laboratories in 2011.”
It was hailed a wonder drug, and as antidepressant Prozac turns 25 years old in January, its popularity is still on the rise.
When should the bereaved be medicated? For years, the official handbook of psychiatry advised against diagnosing major depression when the distress is “better accounted for by bereavement.” Such grief, experts said, was better left to nature. But that may be changing.
How the Media Distort Findings and Do Harm to Patients…
Asking not how, but why, 27 people died
“It was so bad,” said Patricia Shane of Chapmansboro, “that she couldn’t move. She was catatonic.”
Four atypical antipsychotics most commonly prescribed off-label for use in patients aged at least 40 years were found to lack effectiveness and safety, according to the results of a 5-year comparison study.
Liz Fowler again exemplifies the blurred lines between the healthcare industry and Washington
Drug companies’ close involvement in trials of their own products means we can’t trust the results, an investigation shows.
Earlier this year, the medical establishment was rocked when pharmaceuticals giant GlaxoSmithKline reached a record-breaking $3bn settlement with US authorities for illegally promoting drugs to treat conditions they weren’t designed to fix.
Poor oral health is linked to so many diseases, but would you think that it can actually lead slowly to one of the most feared cognitive diseases?
Perhaps we should start with the bad news first. The strongest scientific evidence we have is not how well antidepressants work, but how badly they perform and how harmful they may be to certain individuals.
The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products – and nobody can stop it.
Researchers compared data from 1988-94 with data from 2005-08 and found that the rate of antidepressant use increased nearly 400 percent.
“…many people rely on prescription drugs to treat their depression, sometimes not fully understanding the risks involved with the medication.”
“…for instance, from WebMD’s general depression information page, an editorial link to a “Depression Quiz” takes you to a depression screening page, funded by Lilly, which makes the antidepressant Cymbalta.”
Women who take a popular class of antidepressants during pregnancy may be risking the health of their developing fetus, and the risk may outweigh any benefit to the mother, a new review of data suggests.
Women who take anti-depressants during pregnancy are endangering their unborn babies, experts have warned. The widely prescribed pills have been found drastically to raise the odds of miscarriages, premature birth, autism and life-threatening high blood pressure, they said.
Doctors use different standards to judge scientific research depending on who funded it. They judge research funded by industry as less rigorous, have less confidence in the results, and are less likely to prescribe new drugs than when the funding source is either the NIH or unknown – even when the apparent quality of the research is the same.
Monster Energy Drink has been cited for the deaths of five people and one nonfatal heart attack, according to incident reports submitted to the U.S. Food and Drug Administration.
It was the theory that coaxed the ”black dog” out of hiding…
… therapeutic levels of the anti-depressant mirtazapine and prescription sleeping pill Lunesta were found in Scott’s system at the time of his death. Side effects of mirtazapine can include general symptoms of malaise, but more rarely, can result in severe mood changes and hallucinations, according to Mayo Clinic.
The pharmaceutical industry and organized psychiatry act as if the greatest challenge today is to identify new psychiatric disorders, to promote the supposedly high prevalence of existing disorders, and to find new blockbuster drugs, all the while heavily promoting current moneymakers.
Selective serotonin reuptake inhibitors (SSRI) may be outliving its welcome as a drug of choice for depression, anxiety disorder and other personality disorders.
The investigators looked at long-term data from nearly 1.2 million Swedish psychiatric patients and their relatives, and found that bipolar disorder was more common among people with artistic or scientific professions, such as dancers, photographers, authors and researchers.
“Based on data released by those responsible for the health and well-being of the troops, it seems that pharmacology has replaced compassion. The days of talk therapy, a kind of willingness to stand in the warrior’s boots by listening to his experiences, has been replaced by the quick pop-a-pill fix…”
a new study has revealed that both maternal depression and a common kind of antidepressant are two big environmental issues, which can alter when this learning phase begins in children – ultimately affecting their ability to learn how to speak.
There is good news and bad news about attention deficit/hyperactivity disorder (ADHD) – that is, if you’re a drug company. The bad news is the kid market has peaked out with 4.5 million U.S. children now carrying the label. The good news is adult ADHD is an emerging market.
People involved in car accidents are more likely to have taken psychotropic drugs for a period of days, weeks or months, according to a study published in the British Journal of Clinical Pharmacology.
“…the global pharmaceutical industry has been fined more than $11bn in the last three years for nothing less than criminal wrongdoing. There has been clear promotion of drugs for use beyond the conditions for which they are legally licensed. Also there was evidence of Big Pharma withholding data that queried drug safety.”
Big Pharma’s image problem, fueled by numerous high-profile scandals, may have made doctors so skeptical of the industry that it’s warping their judgment, a new survey suggests.
When the most effective means of smoking cessation are sidelined in favour of inferior products, are we looking at venal corporatism at its most despicable?
Government Addresses Suicides Without Looking at Suicide-Linked Drugs: It would be laughable if it weren’t tragic. This week Surgeon General Regina Benjamin introduced a plan to stem the nation’s growing suicide rate without addressing the nation’s growing use of suicide-linked drugs.
Business executives may not know it, but they are wasting billions of their gross profits on ineffective, even harmful drugs in their health plans.
Thomas Szasz, a psychiatrist whose 1961 book “The Myth of Mental Illness” questioned the legitimacy of his field and provided the intellectual grounding for generations of critics, patient advocates and antipsychiatry activists, making enemies of many fellow doctors, died Saturday at his home in Manlius, N.Y. He was 92.
Mass killings by a lone gunman lead to speculation about the sanity – or lack of it – of the killer who often turns out to have expressed doubts about his own mental stability prior to the attack.
Blame electricity, Big Pharma and the Industrial Revolution. A review of Dreamland: Adventures in the Strange Science of Sleep, by David K. Randall.
“Because psychiatric diagnoses are based on the subjective interpretation of behaviour by third parties. A psychiatrist may be highly trained but their diagnosis is still subjective.”
Psychologists have traditionally not been allowed to prescribe medications for their patients, but some argue that giving them this right would be better for patients, and is also vital to the future of the profession
In eight to 10 weeks, health communications firm Catalina Health and three drugmakers are slated to find out if their effort to simplify drug information is working.
The proposal by the American Psychiatric Association to create a new illness – prolonged grief disorder – and to redefine children’s mental health is the stuff of dreams for Big Pharma.
Parents of a South Dakota teenager who committed suicide while taking the antidepressant Cymbalta can sue the drug’s makers for failure to warn and deceit, the 8th Circuit ruled.
Big Pharma might be working a lot harder to sell you products than to develop new ones.
Were Antidepressants to Blame?
“The Associated Press has reported that the improper marketing to doctors included expensive resort vacations, European hunting trips, high-paid speaking tours, and even tickets to a Madonna concert.”
“…Glaxo marketed Wellubtrin for off-label use to treat a wide range of conditions, including anxiety, biopolar disorder, obesity, sexual dysfunction, weight loss, and more, despite the fact that it was not approved to treat any of them and lacked appropriate research findings to justify those uses.”
“She said, ‘Let’s call it Generalized Anxiety Disorder with a touch of social phobia,'”
Two researchers say calling these medications “antidepressants” may make marketing sense — but it’s not very scientific.
Bribery, fraud, price fixing now a matter of public record.
International Society For Ethical Psychology And Psychiatry Lends Its Support To Coalition For DSM-5 Reform(Posted July 9, 2012 on Coalition for DSM-5 Reform) http://dsm5-reform.com/2012/07/international-society-for-ethical-psychology-and-psychiatry-lends-its-support-with-this-letter/
It is the position of the International Society for Ethical Psychology and Psychiatry (ISEPP) that the Diagnostic and Statistical Manual for Mental Disorders (DSM), a publication of the American Psychiatric Association, is a political rather than scientific document, one which damages human beings. Despite the position of its authors that it is primarily descriptive, the DSM supports the perpetuation of myths about mental, emotional, and behavioral disturbances in individuals which favor pseudoscientific, biological explanations and disregard their lived context.
Post-marketing studies are often used as ploys to get doctors in the habit of prescribing expensive new medicines.
Stress really does mess with your mind.
The Drug Industry’s Grip on Our Health and Lives
Weight gain is listed among the side effects commonly experienced among patients on antidepressants.
Are we exposing millions of pregnant women and their babies to a class of drugs that are causing significantly more harm than good?
Industry could face smaller market but much tighter price controls.
(Posted May 27, 2012 on The Legal Examiner)http://cherryhill.injuryboard.com/fda-and-prescription-drugs/lets-stop-coddling-big-pharma-fraud.aspx?googleid=301330
Opinion piece on Injury Board.
Opinion piece from author on children’s health.
“Psychiatric diagnosis is simply too important to be left exclusively in the hands of psychiatrists. They will always be an essential part of the mix but should no longer be permitted to call all the shots.”
Since direct-to-consumer drug advertising debuted in the late 1990s, the number of people on prescription drugs for life has ballooned.
“…there has been no similar warnings about their link to violence, even though it is well-documented that these drugs cause some people to become agitated and unbalanced.”
Treating Depression When Medication Fails
Tapering slowly is the mantra for pruning these regimens, but some patients may still experience withdrawal symptoms.
“Contrary to popular belief, however, the newer generations of antidepressants don’t work any better than the old ones, with the possible exception of the dual reuptake inhibitors.”
A new review of trials on commonly prescribed antidepressants shows these drugs have only about a 50-50 percent chance of successfully treating depression, despite reports of far higher success rates.
Reye syndrome is an extremely rare but severe and often fatal disease. Death occurs in about 30-40% of cases from brainstem dysfunction. The disease typically is preceded by a viral infection an intermediate disease-free interval of 3-5 days.